Cite
HARVARD Citation
Peyrin-Biroulet, L. et al. (n.d.). S734 Etrasimod 2mg Once Daily as Treatment for Patients With Moderately to Severely Active Ulcerative Colitis: Topline and Subgroup Analysis From ELEVATE UC 52 and ELEVATE UC 12. American journal of gastroenterology. pp. e516-e517. [Online].